NRX Pharmaceuticals Inc (NASDAQ: NRXP) started the day on Thursday, with a price increase of 3.90% at $2.93, before settling in for the price of $2.82 at the close. Taking a more long-term approach, NRXP posted a 52-week range of $1.90-$12.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 45.50%. This publicly-traded company’s shares outstanding now amounts to $8.39 million, simultaneously with a float of $7.64 million. The organization now has a market capitalization sitting at $28.04 million. At the time of writing, stock’s 50-day Moving Average stood at $4.43, while the 200-day Moving Average is $3.71.
NRX Pharmaceuticals Inc (NRXP) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. NRX Pharmaceuticals Inc’s current insider ownership accounts for 20.20%, in contrast to 4.20% institutional ownership. According to the most recent insider trade that took place on Aug 30 ’23, this organization’s Director bought 70,000 shares at the rate of 0.29, making the entire transaction reach 20,125 in total value, affecting insider ownership by 570,000. Preceding that transaction, on Aug 30 ’23, Company’s Director bought 35,000 for 0.32, making the whole transaction’s value amount to 11,196. This particular insider is now the holder of 105,000 in total.
NRX Pharmaceuticals Inc (NRXP) Earnings and Revenue Records
NRX Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 45.50% and is forecasted to reach -2.10 in the upcoming year.
NRX Pharmaceuticals Inc (NASDAQ: NRXP) Trading Performance Indicators
Let’s observe the current performance indicators for NRX Pharmaceuticals Inc (NRXP). It’s Quick Ratio in the last reported quarter now stands at 0.36. The Stock has managed to achieve an average true range (ATR) of 0.58.
In the same vein, NRXP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.54, a figure that is expected to reach -0.55 in the next quarter, and analysts are predicting that it will be -2.10 at the market close of one year from today.
Technical Analysis of NRX Pharmaceuticals Inc (NRXP)
If we take a close look at the recent performances of NRX Pharmaceuticals Inc (NASDAQ: NRXP), its last 5-days Average volume was 2.33 million that shows progress from its year to date volume of 0.31 million. During the previous 9 days, stock’s Stochastic %D was recorded 49.40% While, its Average True Range was 0.57.
Raw Stochastic average of NRX Pharmaceuticals Inc (NRXP) in the period of the previous 100 days is set at 18.96%, which indicates a major fall in contrast to 53.37% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 232.21% that was higher than 172.05% volatility it exhibited in the past 100-days period.
